Immunohistochemistry (IHC) Industry
Description
Wiseguyreports.Com Adds “Immunohistochemistry (IHC) -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2023” To Its Research Database
Immunohistochemistry (IHC) is an umbrella term which combines immunological, biochemical and anatomical techniques to image and localize discrete components in tissues with the help of antibodiesantigen interaction. The use of IHC helps in the documentation and visualization of the high-resolution distribution of cellular components and localization of the antigens of the cells within their proper histological context. The unique properties of IHC testing to precisely localize the antigens, identify the cell type and the tumor, has leveraged its wide adoption in diagnosis, drug development and biological research. IHC tests are employed as a confirmatory procedure or a primary tool for the diagnosis of
various diseases including cancer, cardiovascular, infectious and other diseases.
The author reached out to many industry contacts, including Chris La Placa, who is a histotechnologist at BIO SB Inc. Chris has many years of hands-on experience, so it is instructive that he says Quote: “I agree that the value of the IHC industry is growing and will continue to grow in the coming years. Many pathologists have previously used more basic tissue stains to identify entire structures within human tissue, but IHC is an advantage as it can identify individual proteins. Its application in diagnosing infectious diseases such as syphilis and tuberculosis is also growing in popularity. My company distributes primary antibodies with specificity for bacteria such as H. pylori, T. pallidum, T. gondii, and P. jirovecii (among many others), and these are some of our top sellers. Additionally, we manufacture and sell anchorage dependent cell lines embedded and mounted to a slide that can be stained by IHC. These can be used as controls for validation of patient tissues and are of great interest to pathologists around the world.”
Request for Sample Report @ https://www.wiseguyreports.com/sample-request/3272370-immunohistochemistry-ihc-global-markets-to-2022
Continuous technology and methodological improvements adds value to this type of field especially, where small details and time savings make can make a big difference. For Peter Rauch an MD at Candor Bioscience GMBH we asked which immunoassay solution is the most widely adopted immunoassay in their operating region?
Quote: “For us it is the ELISA market, where we sell most of our products, including the wide range of commercial diagnostic ELISA.” Understanding regional variations can be an effective way to optimize business approaches in a fast changing landscape.
The global Immunohistochemistry market is projected to rise at a CAGR of REDACTED during the forecast period of 2017 through 2022. In 2022, total revenues are expected to reach more than REDACTED,registering an increment from REDACTED in 2017.
The report provides an analysis based on each market segment which includes products, applications and end users. The product segment is further sub-segmented into IHC antibodies, reagents, kits and equipment. The antibodies held the largest market share of REDACTED in 2017 in terms of revenue followed by reagents, equipment and kits. By 2022, total revenue from the antibodies segment is expected toreach more than REDACTED. Whereas, the reagents segment is estimated to rise at the highest CAGR of REDACTED through 2022. Total revenue from the reagents segment is expected to reach REDACTED million by 2022.
Table of Contents
Chapter 1 Introduction
Study Goals and Objectives
Definition of Immunohistochemistry
Scope of Report
Intended Audience
Research Methodology and Information Sources
Analyst’s Credentials
Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Market and Technology Background
Chapter 4 Market Breakdown by Product
Chapter 5 Market Breakdown by Application
Chapter 6 Market Breakdown by End User
Chapter 7 Market Breakdown by Region
Chapter 8 Market Drivers
Chapter 9 Company Profiles and Vendor Landscape
ABBOTT LABORATORIES
ABCAM
ABNOVA
AGILENT TECHNOLOGIES INC.
ARRAYIT CORP.
BIO SB
BIOCARE MEDICAL
BIOGENEX
BIOLEGEND
BIO-RAD LABORATORIES INC.
CANDOR BIOSCIENCE GMBH
CELL MARQUE CORP.
CELL SIGNALING TECHNOLOGY INC.
DANAHER CORP.
DIAGNOSTIC BIOSYSTEMS INC.
F. HOFFMANN-LA ROCHE AG
HISTOLOGIX
IMMUNOLOGIC
LSBIO
MERCK MILLIPORE
NOVODIAX
PEPROTECH GMBH
PERKINELMER INC.
ROCKLAND IMMUNOCHEMICALS
SAKURA FINETEK USA INC.
SIEMENS AG HEALTHCARE
THERMO FISHER SCIENTIFIC INC.
VECTOR LABORATORIES
Leave a Query @ https://www.wiseguyreports.com/enquiry/3272370-immunohistochemistry-ihc-global-markets-to-2022
Continued…
Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (Us) Ph: +44 208 133 9349 (Uk)
Your information will never be shared with any third party.